Heroin use and the high fatality associated with heroin intoxication is once again on the rise in many societies. Treatment strategies for heroin abuse have traditionally targeted mu-opioid receptors (muORs) since heroin metabolites, e.g., morphine, selectively bind to this receptor subtype. In recent years evidence has accumulated to suggest that heroin abuse might also impair kappa-opioid receptor (kappaOR) function as a consequence of the disturbance to the normal homeostatic balance existing between the kappaOR and muOR opiate systems. kappaORs are the primary pharmacological target of dynorphyn (DYN) peptides and produce a number of behavioral and neurochemical effects that oppose those of muORs. The psychopathological disturbances including dysphoria evident in heroin abusers might result from an increase in activity of the DYN/kappaOR system known to regulate negative mood states. Very limited information currently exists as to what extent and where alterations to the DYN/kappaOR are manifested in the brains of heroin abusers. A likely site for DYN/kappa dysfunction related to heroin abuse is in the mesolimbic system, the proposed neuroanatomical substrate for reward and emotional regulation. It is the goal of this project to determine the neural actions of heroin on the DYN/kappa system, at the level of gene expression, peptide production, and receptor function by (1) postmortem analyses of discrete mesolimbic neuronal populations in human heroin addicts and (2) utilization of an experimental rat addiction model to characterize the time course of these changes. In situ hybridization histochemistry will be used to measure mRNA expression levels, western blot analyses to detect the translated proDYN peptide, radioimmunoassay to measure post-translational DYN A and B peptides, ligand binding autoradiography to assess opioid receptor binding sites, and guanosine triphosphate (GTP)-gammaS-stimulated binding to determine the efficacy of kappaOR stimulation as a consequence of the repeated use of heroin. The multilevel approach to the study will ensure a greater understanding of the DYN/kappaOR organization and regulation. By characterizing the DYN/kappa-related mesolimbic circuits in human heroin users, it might also be possible to develop even more effective therapeutic interventions for opiate abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA015446-01
Application #
6508567
Study Section
Special Emphasis Panel (ZRG1-IFCN-3 (03))
Program Officer
Stanford, Laurence
Project Start
2002-09-30
Project End
2008-01-31
Budget Start
2002-09-30
Budget End
2004-01-31
Support Year
1
Fiscal Year
2002
Total Cost
$266,202
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 7-7
Egervari, Gabor; Kozlenkov, Alexey; Dracheva, Stella et al. (2018) Molecular windows into the human brain for psychiatric disorders. Mol Psychiatry :
Fullard, John F; Hauberg, Mads E; Bendl, Jaroslav et al. (2018) An atlas of chromatin accessibility in the adult human brain. Genome Res 28:1243-1252
Mazzone, C M; Pati, D; Michaelides, M et al. (2018) Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior. Mol Psychiatry 23:143-153
Hurd, Yasmin L; O'Brien, Charles P (2018) Molecular Genetics and New Medication Strategies for Opioid Addiction. Am J Psychiatry 175:935-942
Egervari, Gabor; Ciccocioppo, Roberto; Jentsch, J David et al. (2018) Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms. Neurosci Biobehav Rev 85:117-125
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Egervari, Gabor; Landry, Joseph; Callens, James et al. (2017) Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target. Biol Psychiatry 81:585-594
Kozlenkov, Alexey; Wang, Minghui; Roussos, Panos et al. (2016) Substantial DNA methylation differences between two major neuronal subtypes in human brain. Nucleic Acids Res 44:2593-612
Urban, Daniel J; Zhu, Hu; Marcinkiewcz, Catherine A et al. (2016) Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. Neuropsychopharmacology 41:1404-15
Egervari, Gabor; Jutras-Aswad, Didier; Landry, Joseph et al. (2016) A Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. Neuropsychopharmacology 41:2512-20

Showing the most recent 10 out of 37 publications